BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 22430670)

  • 1. Level VI lymph node dissection does not decrease radioiodine uptake in patients undergoing radioiodine ablation for differentiated thyroid cancer.
    Yoo D; Ajmal S; Gowda S; Machan J; Monchik J; Mazzaglia P
    World J Surg; 2012 Jun; 36(6):1255-61. PubMed ID: 22430670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer.
    Hughes DT; White ML; Miller BS; Gauger PG; Burney RE; Doherty GM
    Surgery; 2010 Dec; 148(6):1100-6; discussion 1006-7. PubMed ID: 21134539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location and Causation of Residual Lymph Node Metastasis After Surgical Treatment of Regionally Advanced Differentiated Thyroid Cancer.
    Miller JE; Al-Attar NC; Brown OH; Shaughness GG; Rosculet NP; Avram AM; Hughes DT
    Thyroid; 2018 May; 28(5):593-600. PubMed ID: 29562827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
    Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
    Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
    Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
    Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection.
    Laird AM; Gauger PG; Miller BS; Doherty GM
    World J Surg; 2012 Jun; 36(6):1268-73. PubMed ID: 22270997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.
    Conzo G; Mauriello C; Docimo G; Gambardella C; Thomas G; Cavallo F; Tartaglia E; Napolitano S; Varriale R; Rossetti G; Fei L; Santini L
    Int J Surg; 2014; 12 Suppl 1():S194-7. PubMed ID: 24862675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer.
    de Meer SG; Dauwan M; de Keizer B; Valk GD; Borel Rinkes IH; Vriens MR
    World J Surg; 2012 Jun; 36(6):1262-7. PubMed ID: 22270993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central Lymph Node Dissection Improves Lymph Node Clearance in Papillary Thyroid Cancer Patients with Lateral Neck Metastases, Even after Prior Total Thyroidectomy.
    Hall CM; Snyder SK; Lairmore TC
    Am Surg; 2018 Apr; 84(4):531-536. PubMed ID: 29712601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.
    Ito Y; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    World J Surg; 2010 Jun; 34(6):1285-90. PubMed ID: 20041244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
    Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
    Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.
    Popadich A; Levin O; Lee JC; Smooke-Praw S; Ro K; Fazel M; Arora A; Tolley NS; Palazzo F; Learoyd DL; Sidhu S; Delbridge L; Sywak M; Yeh MW
    Surgery; 2011 Dec; 150(6):1048-57. PubMed ID: 22136820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW; Calsolari MR
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.
    Bonnet S; Hartl D; Leboulleux S; Baudin E; Lumbroso JD; Al Ghuzlan A; Chami L; Schlumberger M; Travagli JP
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1162-7. PubMed ID: 19116234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study.
    Conzo G; Docimo G; Pasquali D; Mauriello C; Gambardella C; Esposito D; Tartaglia E; Della Pietra C; Napolitano S; Rizzuto A; Santini L
    BMC Surg; 2013; 13 Suppl 2(Suppl 2):S3. PubMed ID: 24267409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.
    Gambardella C; Tartaglia E; Nunziata A; Izzo G; Siciliano G; Cavallo F; Mauriello C; Napolitano S; Thomas G; Testa D; Rossetti G; Sanguinetti A; Avenia N; Conzo G
    World J Surg Oncol; 2016 Sep; 14(1):247. PubMed ID: 27644091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications.
    So YK; Seo MY; Son YI
    Surgery; 2012 Feb; 151(2):192-8. PubMed ID: 21497873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma.
    Wu X; Gu H; Gao Y; Li B; Fan R
    Nucl Med Commun; 2018 Jan; 39(1):22-27. PubMed ID: 29135721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.